CLINICAL TRIALS PROFILE FOR TECARTUS
✉ Email this page to a colleague
All Clinical Trials for TECARTUS
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03642626 ↗ | MT2017-45: CAR-T Cell Therapy for Heme Malignancies | Recruiting | Masonic Cancer Center, University of Minnesota | 2018-12-18 | This is a phase II study of FDA-approved CAR-T products for patients with hematologic malignancies. Patients will be assigned to Arm A and B based on age and diagnosis. Overall remission rate, safety events and other endpoints will be calculated for Arm A and B separately. | |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for TECARTUS
Condition Name
Clinical Trial Locations for TECARTUS
Trials by Country
Clinical Trial Progress for TECARTUS
Clinical Trial Phase
Clinical Trial Sponsors for TECARTUS
Sponsor Name